Context. The study of any wild animal's home range requires the collection of spatiotemporal data, obtained independently of climatic conditions or time of day. This can be achieved by the attachment of global positioning system (GPS) data loggers, which, in large species, is best achieved by remote immobilisation. Feral horses (Equus caballus) usually occupy remote areas of Australia; however, a considerable population increase has been observed in a close proximity to metropolitan areas of the Australian east coast, creating increasing conflict with human interests.
Introduction
To safely and humanely place global positioning system (GPS) collars on wildlife, reliable capture methods are essential (Geschke and Chilvers 2009 ). In the case of feral horses, a reliable method of remote immobilisation is necessary to facilitate safe and humane capture and subsequent handling of the subject animal (Kaczenski 2010) . For field anaesthesia to be effective, it should be fast, smooth, reversible and pose minimal safety risks to the target animal and personnel involved in the anaesthetic regimen (Walzer et al. 2006) . Remote immobilisation of wild equids in the field is often perceived to be difficult (e.g. Walzer and Kaczensky 2004) despite a large number of demonstrated techniques for wild herbivore species with similar body size (e.g. Jalanka and Roeken 1990; Tyler et al. 1990; McMahon and Bradshaw 2008; Boardman et al. 2014) .
The most commonly used agent to remotely immobilise non-domesticated equids is the potent opioid etorphine hydrochloride (Matthews and Myers 1993; Walzer et al. 2006; Hampson et al. 2010; Rosu et al. 2012) . Despite its high potency and the availability of an antagonist that enables rapid and complete reversal, etorphine is restricted for use in many countries, including Australia, and difficult to import (Woolnough et al. 2012 ; Australian Government Department of Health and Ageing 2013).
Investigations of alternatives to etorphine have led to use of combinations of a 2 -adrenoceptor agonists (xylazine, detomidine, romifidine, medetomidine) with cyclohexamines (ketamine, tiletamine; Barasona et al. 2013; Matthews et al. 1995; Walzer et al. 2006; Rosu et al. 2012) . In particular, the potent a 2 -adrenoceptor agonist medetomidine, in combination with the cyclohexamine ketamine, has demonstrated reliable and reversible remote immobilisation of a diverse range of ungulate species, including forest reindeer (Rangifer tarandus fennicus), ibex (Capra ibex; Jalanka and Roeken 1990), Przewalski's horse (Equus ferus przewalskii; Matthews et al. 1995) , donkeys (Equus asinus; Woolnough et al. 2012 ) and dromedary camels (Camelus dromedarius; Boardman et al. 2014) . The anaesthetic effects of medetomidine can be reversed, or antagonised, by the a 2 -adrenoceptor antagonist atipamezole, with the effects of cyclohexamines dissipating over time (Woolnough et al. 2012) .
Medetomidine is an a 2 -adrenoceptor antagonist with significant sedative and analgesic properties that provides muscle relaxation and allows smooth induction and recovery from anaesthesia (Muir and Hubbell 2009 ). Ketamine and the closely related tiletamine cause dissociative anaesthesia characterised by catalepsy, amnesia and analgesia (Muir et al. 2000; Muir and Hubbell 2009) . Zolazepam is a benzodiazepinelike drug with sedative and muscle relaxation effects (Muir et al. 2000) . Tiletamine is commercially available combined with zolazepam (Zoletil ® (Virbac, Milperra, NSW) or Telazol ® (Zoetis, Kalamazoo, MI)), a benzodiazepine-like tranquilliser (Muir et al. 2000) . The advantage of the medetomidine and tiletamine-zolazepam combination is that it acts synergistically, with lower doses required, and offers broad anaesthesia safety margins, well-preserved cardiovascular function and muscle relaxation (Jalanka and Roeken 1990) . However, these effects sometimes result in prolonged recovery and there is no readily available antagonist, or reversal agent (Matthews et al. 1991; Muir et al. 2000) . The solubility of the concentrated ketamine preparations is insufficient to allow dosing darts with a capacity restricted to 3 mL. In contrast, the advantage of using the tiletamine-zolazepam combination over ketamine is its superior solubility, permitting very high drug concentrations in minimal volumes (Matthews and Myers 1993) , which, in turn, permits the use of darts of smaller capacity (such as the Pneu-dart tracker dart (Pneu-Dart, Williamsport, PA) with a capacity of 3.0 mL used in the present study). In addition, the combination improves the reliability of sedative properties of either drug alone (tiletamine or zolazepam) without adding extensively to further vital organ depression (Booth and McDonald 1988) . The combination of medetomidine and tiletamine-zolazepam has not been tested previously in remote immobilisation of feral horses under field conditions. Therefore, the purpose of the present study was to investigate the efficacy of medetomidine in combination with tiletamine-zolazepam as a case study for remote immobilisation of nine feral horses for the placement of GPS collars. Anaesthetic and physiological data were collected in order to evaluate the efficiency and safety of this drug combination to provide rapid and smooth induction by remote intramuscular injection, and to be easily reversible, which will provide an effective form of anaesthetic for shorter field procedures performed on feral horses.
Materials and methods

Study area
The study was conducted in the Tuan and Toolara State Forest (TTSF), located in south-east Queensland, Australia (25 53 0 S, 152 50 0 E; Fig. 1 ) between August and November 2013. The mean temperatures during the study were in the range 20.4-27.0
• C (Bureau of Meteorology 2013, available at http:// www.bom.gov.au/jsp/ncc/cdio/weatherData/av?p_nccObsCode =136&p_display_type=dailyDataFile&p_startYear=2013&p_c =-328943740&p_stn_num=40555, accessed 12 December 2013). High environmental temperatures need to be considered when performing general anaesthesia in the field with regard to potential hyperthermia of immobilised animals (Geschke and Chilvers 2009; Berger et al. 2010; Woolnough et al. 2012) .
Animals
The horses involved in the present study were members of established breeding groups (n = 9), which were a part of a larger observational study. Individual horses were selected randomly and included mature males (n = 7) and females (n = 2). Selected horses were healthy in appearance with an estimated bodyweight based on visual appraisal of 400-500 kg. Selected females were not obviously pregnant and were without dependent foals.
Immobilisation procedure
All horses in the study were immobilised with medetomidine hydrochloride (Bova Compounding, Caringbah, NSW, Australia) and tiletamine-zolazepam (Zoletil; Virbac, Milperra, NSW, Australia), which is a soluble powder consisting of equal parts of tiletamine and zolazepam. All horses received the same drug dose, which was approximated for a 450-kg animal. Medetomidine (60 mg; at concentration of 40 mg mL -1 ) was mixed with 750 mg tiletamine powder, 750 mg zolazepam powder and 0.5 mL saline. Following several attempts to solubilise the tiletamine-zolazepam powder using only medetomidine, it was ascertained that 0.5 mL sterile saline facilitated the solubilisation process, as well as providing a balanced dart volume. Remote injection of the anaesthetic agents was facilitated by 3 mL C-type explosive-powered metal darts equipped with very high frequency (VHF) transmitters (Pneu-Dart, Williamsport, PA, USA) which enabled location of the darted animals in dense forested vegetation using a Yagi antenna (Sirtrack, Havelock North, New Zealand). This requirement limited the available dart volume to 3 mL because of the commercial availability of tracking darts. Darts were fitted with 3.8-cm wire twin-barbed needles (Pneu-Dart) and were delivered using an x-calibre CO 2 -powered dart gun (Pneu-Dart). Because transmitters added considerable weight to the dart, the shooting range to horses non-habituated to human presence was reduced to 40 m. Remote immobilisation was performed by a professional shooter and supervised by a veterinarian.
All animals were approached on foot and were darted while standing or grazing; the chosen darting site was the lateral shoulder, neck or rump and the intended injection route was intramuscular (i.m.). The distance travelled by each horse was measured by a GPS (Garmin Oregon 550; Garmin International, Olathe, KA, USA) and reported distances are from the last successful dart. Immobilisation was deemed to be achieved when the darted animal was observed to be in lateral recumbency (as per Walzer et al. 2006) . Once immobilised, horses were approached quietly from behind and sometimes repositioned to avoid rocks and vegetation, or to reduce visceral pressure on the diaphragm secondary to headdownhill positioning. Animals were blindfolded with a blanket to reduce visual stimulation and to diminish potential injury to their eyes.
Anaesthetic monitoring of physiological parameters was performed immediately after lateral recumbency was achieved and then every 15 min until the animal was standing. Heart rate was recorded by auscultation, respiratory rate by counting chest excursions, pulse strength by digital pressure of the facial artery and body temperature by a thermometer placed in the rectum. Mucous membrane colour, capillary refill time, palpebral reflex response and anal tone were also evaluated. Haemoglobin saturation (S p O 2 ) was measured by a battery-powered c-clamp pulse oximeter (Edan, San Diego, CA, USA) placed on the tongue. Oxygen supplementation via nasal insufflations at 10 L min -1 was administered when S p O 2 fell below 90%. Oxygen was delivered from a portable high-pressure cylinder (BOC Australia, Sydney) fitted with a regulator flow meter and connected to the horse by 3 m of 14-mm internal diameter plastic tubing.
Bodyweight was calculated while the animal was anaesthetised and in lateral recumbency using the formula of Carroll and Huntington (1988) :
The perpendicular distance from the dorsal midline immediately caudal to the withers and the ventral midline was doubled to provide the girth measurement. The distance from point of hip to point of shoulder was measured as being representative of body length (Milner and Hewitt 1969) and the divisor Y was equal to 11 900 (Carroll and Huntington 1988) . This calculation allowed approximation of drug administered per kg of horse. Age was approximated by dental examination (as per Baker and Easley 1999) .
Time to lateral recumbency was measured as the time from first dart placement to the time the horse became recumbent (as per Woolnough et al. 2012) . In horses darted multiple times, some darts bounced off or embedded in superficial tissues. In horses darted with more than one dart, time to lateral recumbency was measured from the successful delivery of the last dart to lateral recumbency. Drug absorption from these ineffective darts was assumed to be zero (as per Woolnough et al. 2012 ) and they were not included for calculation of final drug dosage. Total recumbency time was measured from initial recumbency to standing in minutes.
Immobilisation was reversed with an initial dose of 50 mg atipamezole (Illium Atipamezole; Troy Laboratories, Glendenning, NSW, Australia; 5 mg mL -1 , i.v. and/or i.m.) 30-40 min after induction. If the recovery was prolonged, then an additional dose of atipamezole equal to 25 mg, i.v., was given 25 and 60 min after the initial dose. Recovery time was measured in minutes as the time from first administration of atipamezole to the time the horse stood and remained standing.
Further observations were performed from a safe distance to ensure recovery was complete, which was determined as sufficient muscular strength and coordination of movements to remain standing (Clark-Price 2013). Within 24-48 h of recovery, all horses were reassessed to see whether they were of normal demeanour and that they had returned to their harems. All handling procedures were approved by the University of Queensland Animal Ethics Committee (approval no SVS/215/11/ F.P Qld).
Results are presented as the mean AE s.e.m. and range.
Results
Immobilisation
Drug doses, animal details, induction, anaesthesia and recovery data for all horses are presented in Table 1 . Tabulated drug doses were calculated retrospectively after estimation of bodyweight after darting. Five horses (Animals 1-5) became laterally recumbent after administration of one dart, three horses (Animals 6, 7 and 8) required two darts to become recumbent and one horse (Animal 9) required three darts to achieve lateral recumbency. The mean dose for medetomidine for all nine animals was 0.15 AE 0.01 mg kg -1 and for tiletaminezolazepam was 3.61 AE 0.16 mg kg -1 . In all horses, a stilted gait was observed within 2-3 min of darting, followed by progressive ataxia and lateral recumbency within 13 AE 3 min. Distances travelled by horses after a successful dart varied from 60 to 813 m, and averaged 194 AE 80 m.
Anaesthesia
On average, all horses were laterally recumbent for 54 AE 13 min. All measured variables were within normal ranges for the duration of the anaesthesia in all horses (Table 2) , with the exception of one horse (Animal 1) displaying a transient drop in haemoglobin saturation.
Recovery
Following the administration of atipamezole at a mean of 37 AE 2 min after induction, all horses stood within 31 AE 13 min. In one horse, where 75% of the calculated dose of atipamezole was given i.m. and 25% i.v., totalling 100 mg, the recovery was prolonged and lasted 115 min. In the second horse, in which 25 mg atipamezole was given i.v. and 25 mg i.m., the recovery was rapid and lasted 5 min. Subsequently, the remaining seven horses received 50 mg, i.v., atipamezole. For six horses, the average recovery length was 9.3 AE 3.2 min. One horse experienced a longer recovery; therefore, it further received 25 mg, i.v., atipamezole 25 min after the initial dose and recovered in 37 min. One horse did not recover from the initial dose, so it was subsequently given 25 mg, i.v., atipamezole at 25 min and than again at 60 min after the initial dose, totalling100 mg. The recovery length of this horse was 70 min. Most horses (n = 7; 77.8%) had a smooth recovery, which started with head lifting and progressed to sternal recumbency, followed by less than three attempts to stand. Two (22.2%) horses had shorter recoveries characterised by less than three attempts to stand. Despite remaining standing, all horses appeared moderately sedated, and, if not stimulated, moved very little for the next 3-4 h. If stimulated to move, horses were ataxic, but the full control of body movements returned after 2 h standing.
Eight individuals eventually returned to their harems. One horse rejoined his harem on the same day, five horses the following day and two horses remained by themselves for more than 2 days before rejoining their harems. One horse was euthanised within 16 h of recovery because of an injury sustained during anaesthetic induction. The post-mortem examination revealed that while the horse fell to the ground its bodyweight had driven the dart into the chest cavity causing a pneumothorax and lung collapse.
Discussion
The combination of medetomidine and tiletamine-zolazepam produced adequate short-term immobilisation of all feral horses under field conditions. This is the first known study to have used this drug combination to remotely immobilise freeranging horses. A single 3-mL dart was sufficient to produce immobilisation in 55.6% of horses, with consistently short times to lateral recumbency. Depth of anaesthesia in these horses was variable, but anaesthesia was generally short, and all measured physiological parameters were within normal ranges (Coumbe 2001) . The recoveries varied in time, but were smooth and resulted in no visible injuries to immobilised horses. Similarly, 44.4% of horses that required more than one dart to become recumbent exhibited short times to lateral recumbency after the administration of the final dart. The stability of lateral recumbency in these horses was more variable, as were the average recovery times. The overall recumbency time produced by this combination was longer than for many similar studies (e.g. Woolnough et al. 2012; Boardman et al. 2014) .
In four horses that were not immobilised with one dart, the initial dart bounced off or embedded in the target tissue subcutaneously. As a result, two horses in which the dart bounced off showed a lack of response to the initial drug dose; in the other two instances, responses to the drugs were muted despite at least one of the subsequent darts embedding in the targeted animal's tissues. This procedure agitated the horses and caused them to move, potentially bypassing the sedative effect. It is possible to conclude from these observations that where the dart did not initially lodge, or embed in the subcutaneous tissue, it may not have impacted with adequate force to inject a sufficient volume of drug to cause immobilisation or the drug was subcutaneous and therefore had a slower onset of action (Rosu et al. 2012) . Residual drug present in darts that bounced off the animals was observed but was not measured in the present study. Individual variation of anaesthetic responses varies between animals of the same species, and differences in age, gender, body condition and the physiological state of the animals at the time of drug delivery may potentially affect drug absorption rates (Geschke and Chilvers 2009; Roelle and Ransom 2009) .
Despite the differences in body size between individual horses, it was not possible to constitute and deliver individual drug doses under the field conditions in which the study was conducted. The use of standardised total drug doses, rather than tailored individual doses, is reflected in the variability in drug dosages seen in Table 1 . Measurement of bodyweight after immobilisation in the first four horses indicated that the drug combination dose selected was more appropriate for male horses with a more uniform bodyweight of around 450 kg, hence the preponderance of males in the present study.
In the present study, all animals were darted while standing or grazing, but numerous factors potentially influenced dart performance. For example, thick ground vegetation made it easier for the shooter to approach the horses, but the vegetation impeded progress of the dart. Observations made by the shooter revealed that wind speed affected dart trajectory, which deviated from the target in two instances. Sudden movement of two horses also resulted in darts not embedding in the target tissue correctly.
The dose of medetomidine used in the present study was higher than the dose used in a previous study on use in Przewalski's horses (0.07-0.10 mg kg -1
; Matthews et al. 1995) and slightly higher than that used to immobilise feral donkeys (0.14 mg kg -1 ; Woolnough et al. 2012) . Other studies have shown that comparable doses of medetomidine to those used in the present study have been administered to large ungulates previously without lethal side effects (Tyler et al. 1990; Haulena et al. 2000; Woolnough et al. 2012; Boardman et al. 2014) .
Heart and respiratory rates were within normal ranges, but S p O 2 values showed that haemoglobin saturation decreased with anaesthesia and was of sufficient concern in one horse (11.1%) to warrant the administration of oxygen by nasal insufflation. If nasal oxygen is not available in the field, then anaesthetic duration should be minimised by administering atipamezole as soon as possible to reverse medetomidine. However, the risk of early atipamezole use is that it could lead to residual effects of tiletamine and zolazepam, such as prolonged ataxia and distress to the animal (Muir et al. 2000) . Greater dosing accuracy of medetomidine and tiletamine-zolazepam is also likely to reduce unwanted effects of anaesthesia, such as decreased haemoglobin oxygen saturation (Muir and Hubbell 2009 ). Sedative and anaesthetic agents depress thermoregulatory function and both hypo-and hyperthermia can be significant depending on the ambient temperature and duration of anaesthesia in the field (Delvaux et al. 1999) . The metabolic effects associated with the escape response in wild animals may significantly raise the core, and therefore rectal, temperature of captured animals (Woolnough et al. 2012) . Despite moderately high ambient humidity and temperature during the period over which the darting study occurred, the rectal temperature of immobilised horses remained within the published normal range (Coumbe 2001) .
The use of reversal agents is desirable in feral and wild animal field anaesthesia because it diminishes the risks associated with anaesthetic procedures (Walzer et al. 2006) . In wild animal capture studies involving a 2 -adrenoceptor sedatives, atipamezole has been successfully used to accelerate animal recovery and reduce the costs of anaesthesia monitoring (Matthews et al. 1995; Ramseyer et al. 1998; Hubbell and Muir 2006) . However, the timing of atipamezole administration is important regardless of whether an a 2 -adrenoceptor antagonist is the only drug administered or whether it is combined with other sedatives or anaesthetics. In field anaesthesia, atipamezole administered subcutaneously (s.c.) and i.v. at doses of 0.17-0.23 mg kg -1 30 min after remote delivery of medetomidine and ketamine did not result in complete reversal and was associated with variable recovery times in Przewalski's horses, which was believed to be due to persisting effects of ketamine (Matthews et al. 1995) . Larger doses of atipamezole administered 15 min after medetomidine and ketamine significantly shortened recovery time, but did not eliminate residual effects of ketamine in feral donkeys (Woolnough et al. 2012) .
There is no readily available antagonist for tiletaminezolazepam (Muir and Hubbell 2009 ). Administration of atipamezole in the present study was deliberately delayed to a mean (AE s.e.m.) 37 AE 4 min after induction to ensure that when the effect of medetomidine was neutralised, the residual effects of tiletamine-zolazepam were reduced. Earlier administration of atipamezole would have meant that the level of a-adrenoceptor agonist reversal would have been influenced by the persistence of the tiletamine-zolazepam sedation and arousal would have been diminished. As a result, rapid and smooth recoveries and return to standing were obtained in 77.8% of horses. The approach was similar to that of Woolnough et al. (2012) , where a 2 -adrenoceptor antagonist administration 30-40 min after induction avoided residual ketamine effects and enhanced the smoothness of recoveries.
The anaesthetic time of wild equids should be reduced to a minimum (Walzer et al. 2006; Woolnough et al. 2012 ), but our study reported an extended mean time in lateral recumbency of 54 AE 13 min. For example, the first horse received 75% of the calculated dose of atipamezole by i.m. injection. Time to standing in this horse was slow (115 min), which could have been influenced by the route of administration. Subsequent horses were given 50% (n = 1) or 100% (n = 7) of the calculated atipamezole dose i.v., which considerably shortened their recumbency and recovery times (Table 1 ). When atipamezole was administered i.v., the recovery was considerably more rapid, was associated with a moderate degree of ataxia and, in general, involved a lower dosage. The extended recovery time of the last horse could have been a result of a larger dose of anaesthetic agents received by three consecutive darts. The amount of drug injected from darts that dislodged and/or bounced off was unknown and was assumed to be nil when calculating dose rates; however, some absorption could have occurred. To reduce recumbency times, further research could investigate the combination of the shorter-acting but less soluble ketamine with medetomidine (as per Matthews et al. 1995) in contexts that permit larger dart sizes (helicopter darting, trapped animals). Investigation of adding the enzyme hyaluronidase (as per Cattet and Obbard 2010) may also be warranted to reduce induction times.
Legislative requirements surrounding the use of the potent opiate etorphine are prohibitive in Australia (Australian Government Department of Health and Ageing 2013). The occupational hazards posed by etorphine make it very difficult to acquire licenses to use the drug for operational immobilisation programs (Woolnough et al. 2012) . Less potent opiates, such as butorphanol, are often added to the medetomidine-ketamine combination (e.g. Miller et al. 2009; Boardman et al. 2014) . However, opiates are Schedule 8 drugs in Australia (Australian Government Department of Health and Ageing 2013), reducing their accessibility for field techniques (see Woolnough et al. 2012) . In addition, the high cost of butorphanol, and its antagonist naltrexone, render such regimens relatively expensive compared with methods not including an opiate. For these reasons, an opiate was not included in the immobilisation regimen in the present study. In contrast, the use of medetomidine and tiletamine-zolazepam offers an accessible and practical option for operational control programs of feral animals in the field.
Conclusion
The combination of 60 mg medetomidine and 1500 mg tiletamine-zolazepam allowed safe, partially reversible and cost-effective remote immobilisation of nine feral horses in their natural environment of the TTSF. This approach was practical for the study operators because it only involved the use of three drug preparations and did not require the use of restricted substances. The ability to safely immobilise feral horses for the attachment of telemetry equipment or collection of health and physiological data is important for the understanding of the biology of the species. The practicality of capture techniques is an important consideration for managers to facilitate live removal of feral horses during management operations where lethal methods are not acceptable (Chapple 2005; Nimmo and Miller 2007) . The ability to capture feral horses in the TTSF and similar land tenures by chemical immobilisation will advance current non-lethal management options that are based primarily on mustering and trapping (Berman 2013) . This technique will be of particular importance in the forestry areas located near major public roads, where mustering of animals may increase the risk of collisions with vehicles. Future research should be aimed at optimising dose rates and delivery mechanisms for medetomidine and tiletamine-zolazepam, comparing with medetomidine-ketamine and providing additional information on the safety, efficacy, and physiological responses of horses immobilised with this drug combination.
